← Leaderboards
Erik K Flemington
University Of Florida
$23,678,004
Attributed
$23,994,457
Total exposure
27
Grants
25
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$23,994,457 · 27
By mechanism
R01$15,920,852 · 10
P01$4,408,565 · 6
P20$1,571,812 · 7
U19$1,203,600 · 1
R21$859,237 · 2
P51$30,391 · 1
Top collaborators
- Yan Dong1 shared
Most similar at University Of Florida
Same institution · by research overlap
- Rolf F Renne$15,821,379
- Scott A. Tibbetts$9,656,998
- Carl Atkinson$8,241,342
- Henrietta L Logan$363,745
- Jeongwon Park$538,634
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsHuman Herpesvirus 4MediatingGenesViralGene ExpressionVirusHerpesviridaeMalignant NeoplasmsMicrornasSignal TransductionPlayProgramsResponseProteinsAcquired Immunodeficiency SyndromeHuman Herpesvirus 8OncogenicPathway InteractionsTranscriptBaseS LymphomaGenetic TranscriptionEnvironment
Grant awards (86)
RNA-binding as a new paradigm for androgen receptor-mediated prostate cancer therapeutic resistance$632,906
R01 · FY2025 · CA
Programmed splicing derangement as new EBV host cell shut-off mechanism$426,466
R01 · FY2025 · CA · contact PI
EBV reactivation causes widespread host de novo promoter transcription and transcriptional interference$413,594
R01 · FY2025 · CA · contact PI
"Project 2" Microprocessor overload in gamma-herpesviral oncogenesis$214,547
P01 · FY2025 · CA · contact PI
"Core B" Viral RNA-seq and bioinformatics Core$214,546
P01 · FY2025 · CA · contact PI
Programmed splicing derangement as new EBV host cell shut-off mechanism$405,144
R01 · FY2024 · CA · contact PI
EBV reactivation causes widespread host de novo promoter transcription and transcriptional interference$400,193
R01 · FY2024 · CA · contact PI
"Project 2" Microprocessor overload in gamma-herpesviral oncogenesis$279,237
P01 · FY2024 · CA · contact PI
"Core B" Viral RNA-seq and bioinformatics Core$167,244
P01 · FY2024 · CA · contact PI
Programmed splicing derangement as new EBV host cell shut-off mechanism$417,938
R01 · FY2023 · CA · contact PI
EBV reactivation causes widespread host de novo promoter transcription and transcriptional interference$412,831
R01 · FY2023 · CA · contact PI
RPMS1 circular RNAs in EBV malignancies$358,648
R01 · FY2023 · CA · contact PI
"Project 2" Microprocessor overload in gamma-herpesviral oncogenesis$284,781
P01 · FY2023 · CA · contact PI
"Core B" Viral RNA-seq and bioinformatics Core$162,833
P01 · FY2023 · CA · contact PI
Programmed splicing derangement as new EBV host cell shut-off mechanism$426,466
R01 · FY2022 · CA · contact PI
EBV reactivation causes widespread host de novo promoter transcription and transcriptional interference$421,256
R01 · FY2022 · CA · contact PI
RPMS1 circular RNAs in EBV malignancies$358,645
R01 · FY2022 · CA · contact PI
"Project 2" Microprocessor overload in gamma-herpesviral oncogenesis$280,440
P01 · FY2022 · CA · contact PI
"Core B" Viral RNA-seq and bioinformatics Core$215,214
P01 · FY2022 · CA · contact PI
RPMS1 circular RNAs in EBV malignancies$365,967
R01 · FY2021 · CA · contact PI
"Project 2" Epstein-Barr virus LMP2 IncRNAs$282,729
P01 · FY2021 · CA · contact PI
Project 2: Joint Transcriptomic and Epigenomic Studies for Male Osteoporosis$225,345
U19 · FY2021 · AG · contact PI
"Core B" Virus RNA-seq and Bioinformatics Core$214,684
P01 · FY2021 · CA · contact PI
RPMS1 circular RNAs in EBV malignancies$365,867
R01 · FY2020 · CA · contact PI
"Project 2" Epstein-Barr virus LMP2 IncRNAs$282,729
P01 · FY2020 · CA · contact PI
Project 2: Joint Transcriptomic and Epigenomic Studies for Male Osteoporosis$225,345
U19 · FY2020 · AG · contact PI
"Core B" Virus RNA-seq and Bioinformatics Core$214,684
P01 · FY2020 · CA · contact PI
Assessing the EBV circular RNAome$132,131
R21 · FY2020 · CA · contact PI
RPMS1 circular RNAs in EBV malignancies$364,563
R01 · FY2019 · CA · contact PI
"Project 2" Epstein-Barr virus LMP2 IncRNAs$274,248
P01 · FY2019 · CA · contact PI
Project 2: Joint Transcriptomic and Epigenomic Studies for Male Osteoporosis$233,230
U19 · FY2019 · AG · contact PI
Assessing the EBV circular RNAome$230,279
R21 · FY2019 · CA · contact PI
"Core B" Virus RNA-seq and Bioinformatics Core$208,242
P01 · FY2019 · CA · contact PI
Epstein Barr virus antisense transcription$376,250
R01 · FY2018 · AI · contact PI
"Project 2" Epstein-Barr virus LMP2 IncRNAs$289,846
P01 · FY2018 · CA · contact PI
Project 2: Joint Transcriptomic and Epigenomic Studies for Male Osteoporosis$273,838
U19 · FY2018 · AG · contact PI
"Core B" Virus RNA-seq and Bioinformatics Core$214,241
P01 · FY2018 · CA · contact PI
Epstein Barr virus antisense transcription$376,250
R01 · FY2017 · AI · contact PI
"Project 2" Epstein-Barr virus LMP2 IncRNAs$330,828
P01 · FY2017 · CA · contact PI
"Core B" Virus RNA-seq and Bioinformatics Core$277,492
P01 · FY2017 · CA · contact PI
Project 2: Joint Transcriptomic and Epigenomic Studies for Male Osteoporosis$245,842
U19 · FY2017 · AG · contact PI
Epstein Barr virus antisense transcription$376,250
R01 · FY2016 · AI · contact PI
Intercellular communication in Epstein Barr virus reactivation$376,250
R01 · FY2016 · AI · contact PI
Epstein Barr virus antisense transcription$376,250
R01 · FY2015 · AI · contact PI
Intercellular communication in Epstein Barr virus reactivation$376,250
R01 · FY2015 · AI · contact PI
Epstein Barr virus antisense transcription$376,250
R01 · FY2014 · AI · contact PI
Intercellular communication in Epstein Barr virus reactivation$376,250
R01 · FY2014 · AI · contact PI
Intercellular communication in Epstein Barr virus reactivation$353,675
R01 · FY2013 · AI · contact PI
Role of the cellular microRNA, miR-155, in EBV type III latency signaling$281,907
R01 · FY2013 · CA · contact PI
Intercellular communication in Epstein Barr virus reactivation$376,250
R01 · FY2012 · AI · contact PI
Role of the cellular microRNA, miR-155, in EBV type III latency signaling$299,900
R01 · FY2012 · CA · contact PI
Analysis of Epstein Barr virus type III latency on cellular miRNA gene expression$299,900
R01 · FY2012 · CA · contact PI
Analysis of Epstein Barr virus type III latency on cellular miRNA gene expression$299,900
R01 · FY2011 · CA · contact PI
Role of the cellular microRNA, miR-155, in EBV type III latency signaling$299,900
R01 · FY2011 · CA · contact PI
Regulation of Epstein Barr virus reactivation through the co-activators, CBP/p300$247,146
R01 · FY2011 · CA · contact PI
TULANE CANCER GENETICS COBRE: CELL ASSAY CORE$152,614
P20 · FY2011 · RR · contact PI
Analysis of Epstein Barr virus type III latency on cellular miRNA gene expression$309,175
R01 · FY2010 · CA · contact PI
Role of the cellular microRNA, miR-155, in EBV type III latency signaling$309,175
R01 · FY2010 · CA · contact PI
Regulation of Epstein Barr virus reactivation through the co-activators, CBP/p300$254,790
R01 · FY2010 · CA · contact PI
TULANE CANCER GENETICS COBRE: CELL ASSAY CORE$181,799
P20 · FY2010 · RR · contact PI
Analysis of Epstein Barr virus type III latency on cellular miRNA gene expression$309,175
R01 · FY2009 · CA · contact PI
Role of the cellular microRNA, miR-155, in EBV type III latency signaling$309,175
R01 · FY2009 · CA · contact PI
Regulation of Epstein Barr virus reactivation through the co-activators, CBP/p300$254,790
R01 · FY2009 · CA · contact PI
Analysis of Epstein Barr virus type III latency on cellular miRNA gene expression$219,187
R01 · FY2009 · CA · contact PI
TULANE CANCER GENETICS COBRE: CELL ASSAY CORE$129,243
P20 · FY2009 · RR · contact PI
Analysis of Epstein Barr virus type III latency on cellular miRNA gene expression$309,175
R01 · FY2008 · CA · contact PI
Regulation of Epstein Barr virus reactivation through the co-activators, CBP/p300$254,790
R01 · FY2008 · CA · contact PI
TULANE CANCER GENETICS COBRE: CELL ASSAY CORE$148,875
P20 · FY2008 · RR · contact PI
Regulation of Epstein Barr virus reactivation through the co-activators, CBP/p300$254,790
R01 · FY2007 · CA · contact PI
Characterization of the EBV BZLF1 Gene Product$226,047
R01 · FY2007 · GM · contact PI
TULANE CANCER GENETICS COBRE: CELL ASSAY CORE$188,539
P20 · FY2007 · RR · contact PI
REGULATION OF CBP/P300 TRANSACTIVATION BY E2FI$30,391
P51 · FY2007 · RR · contact PI
Characterization of the EBV BZLF1 Gene Produce$232,016
R01 · FY2006 · GM · contact PI
Analysis of EBNA1 siRNA for inhibiting NPC tumor growth$181,264
R21 · FY2006 · DE · contact PI
TULANE CANCER GENETICS COBRE: CELL ASSAY CORE$169,174
P20 · FY2006 · RR · contact PI
Analysis of EBNA1 siRNA for inhibiting NPC tumor growth$92,813
R21 · FY2006 · DE · contact PI
Characterization of the EBV BZLF1 Gene Produce$92,070
R01 · FY2006 · GM · contact PI
TULANE CANCER GENETICS COBRE: CELL ASSAY CORE$290,070
P20 · FY2005 · RR
Characterization of the EBV BZLF1 Gene Produce$284,581
R01 · FY2005 · GM
Analysis of EBNA1 siRNA for inhibiting NPC tumor growth$222,750
R21 · FY2005 · DE
CORE--TULANE CANCER GENETICS COBRE: CELL ASSAY$311,498
P20 · FY2004 · RR
Characterization of the EBV BZLF1 Gene Produce$283,386
R01 · FY2004 · GM
Characterization of the EBV BZLF1 Gene Product$282,224
R01 · FY2003 · GM
EBV BZLF1 GENE PRODUCT$239,669
R01 · FY2001 · GM
EBV BZLF1 GENE PRODUCT$220,544
R01 · FY2000 · GM
EBV BZLF1 GENE PRODUCT$37,031
R01 · FY2000 · GM